Cargando…

Hypoxia Promotes Dopaminergic Differentiation of Mesenchymal Stem Cells and Shows Benefits for Transplantation in a Rat Model of Parkinson’s Disease

Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into dopaminergic (DAergic) neurons, which is one of the major cell types damaged in Parkinson’s disease (PD). For this reason, MSCs are considered a potential cell source for PD therapy. It has been proved that hypoxia i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yue, Yang, Jian, Li, Haisheng, Wang, Xuan, Zhu, Lingling, Fan, Ming, Wang, Xiaomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546985/ https://www.ncbi.nlm.nih.gov/pubmed/23342124 http://dx.doi.org/10.1371/journal.pone.0054296

Ejemplares similares

Hypoxic Culture Promotes Dopaminergic-Neuronal Differentiation of Nasal Olfactory Mucosa Mesenchymal Stem Cells via Upregulation of Hypoxia-Inducible Factor-1α
por: Zhuo, Yi, et al.
Publicado: (2017)

Differentiation of adult human mesenchymal stem cells into dopaminergic neurons
por: Khademizadeh, Marjan, et al.
Publicado: (2019)

Zhichan decoction induces differentiation of dopaminergic neurons in Parkinson's disease rats after neural stem cell transplantation
por: Shi, Huifen, et al.
Publicado: (2014)

Salidroside induces rat mesenchymal stem cells to differentiate into dopaminergic neurons
por: Zhao, Hong-Bin, et al.
Publicado: (2014)

The Efficacy of Graphene Foams for Culturing Mesenchymal Stem Cells and Their Differentiation into Dopaminergic Neurons
por: Tasnim, Nishat, et al.
Publicado: (2018)

The differentiation of human placenta-derived mesenchymal stem cells into dopaminergic cells in vitro
por: Chen, Li, et al.
Publicado: (2009)

The Different Molecular Code in Generation of Dopaminergic Neurons from Astrocytes and Mesenchymal Stem Cells
por: Wang, Nana, et al.
Publicado: (2021)

Caveolin-1 downregulation promotes the dopaminergic neuron-like differentiation of human adipose-derived mesenchymal stem cells
por: Han, Chao, et al.
Publicado: (2020)

Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson’s Disease
por: Hamedi, Helia, et al.
Publicado: (2023)

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis
por: Zhang, Huayong, et al.
Publicado: (2017)

Parkinson’s Disease Subtypes Show a Specific Link between Dopaminergic and Glucose Metabolism in the Striatum
por: Eggers, Carsten, et al.
Publicado: (2014)

Voice Analysis to Differentiate the Dopaminergic Response in People With Parkinson's Disease
por: Jain, Anubhav, et al.
Publicado: (2021)

Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells
por: Altarche-Xifro, Wassim, et al.
Publicado: (2016)

Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats
por: da Silva, Marina de Moraes Carvalho, et al.
Publicado: (2020)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Effect of Hypoxia on the Differentiation and the Self-Renewal of Metanephrogenic Mesenchymal Stem Cells
por: Liu, Shaopeng, et al.
Publicado: (2017)

Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition
por: Rowe, J. B., et al.
Publicado: (2008)

Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson’s disease
por: Weickert, Thomas W., et al.
Publicado: (2013)

Differential dopaminergic modulation of spontaneous cortico–subthalamic activity in Parkinson’s disease
por: Sharma, Abhinav, et al.
Publicado: (2021)

Effect of the PI3K/AKT signaling pathway on hypoxia-induced proliferation and differentiation of bone marrow-derived mesenchymal stem cells
por: Sheng, Lingling, et al.
Publicado: (2017)

Co-Transplantation of GDNF-Overexpressing Neural Stem Cells and Fetal Dopaminergic Neurons Mitigates Motor Symptoms in a Rat Model of Parkinson’s Disease
por: Deng, Xingli, et al.
Publicado: (2013)

Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models
por: Yang, Hanyu, et al.
Publicado: (2020)

Differentiation of rhesus adipose stem cells into dopaminergic neurons☆
por: Zhou, Yan, et al.
Publicado: (2012)

Dopaminergic-like cells from epigenetically reprogrammed mesenchymal stem cells
por: Zhang, Zhiying, et al.
Publicado: (2012)

Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
por: Mao, Qi, et al.
Publicado: (2020)

Effects of Severe Hypoxia on Bone Marrow Mesenchymal Stem Cells Differentiation Potential
por: Cicione, Claudia, et al.
Publicado: (2013)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
por: Aracil‐Bolaños, Ignacio, et al.
Publicado: (2021)

Effects of Feeder Cells on Dopaminergic Differentiation of Human Embryonic Stem Cells
por: Zhao, Zhenqiang, et al.
Publicado: (2016)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease
por: Zhao, Yi, et al.
Publicado: (2018)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Acupuncture for Parkinson's Disease: Efficacy Evaluation and Mechanisms in the Dopaminergic Neural Circuit
por: Zhao, Yadan, et al.
Publicado: (2021)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
por: Yu, Zhongyuan, et al.
Publicado: (2018)

Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects
por: Borgs, Laurence, et al.
Publicado: (2016)

Mouse Embryonic Stem Cells Expressing GDNF Show Enhanced Dopaminergic Differentiation and Promote Behavioral Recovery After Grafting in Parkinsonian Rats
por: Lara-Rodarte, Rolando, et al.
Publicado: (2021)

Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model
por: Yuan, Yanpeng, et al.
Publicado: (2018)

Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease
por: Han, Linlin, et al.
Publicado: (2021)

Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke
por: Wang, Fan, et al.
Publicado: (2018)

Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson’s Disease
por: Zhang, Li, et al.
Publicado: (2018)

Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
por: D’Amico, Ramona, et al.
Publicado: (2022)

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_856dtrbj3mei81uk592f64m204